Pura Vida Investments, LLC Phathom Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$11.55 - $20.06 $6,930 - $12,036	600 Added 0.59%	102,328 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$17.83 - $33.15 $1.23 Million - $2.29 Million	69,153 Added 212.29%	101,728 $2 Million
Q3 2021 Nov 15, 2021	SELL	$30.69 - $36.83 $387,798 - $465,383	-12,636 Reduced 27.95%	32,575 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$32.66 - $39.87 $606,202 - $740,027	-18,561 Reduced 29.11%	45,211 $1.53 Million
Q1 2021 May 12, 2021	BUY	$33.86 - $48.68 $127,719 - $183,620	3,772 Added 6.29%	63,772 $2.4 Million
Q4 2020 Feb 16, 2021	BUY	$33.22 - $50.26 $1.99 Million - $3.02 Million	60,000 New	60,000 $1.99 Million

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $292M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.